A number of factors have reignited the life settlement market with both consumers and investors showing rising interest.
The oldest baby boomers are reaching age 71, which brings them to or near retirement and closer to the age “sweet spot” for life settlements. As baby boomers retire, the need for retirement income can become acute and cash from a life settlement can be an important retirement income supplement.
Cash flow relief can also come from eliminating the premiums necessary to keep policies in force, especially those policies that are requiring substantially greater premiums than projected at purchase due to low interest crediting rates or higher mortality (cost of insurance) charges.
Additionally, as baby boomers continue to age, money becomes necessary to pay for both long-term care and health care. Life settlements can be a source of funds to pay for those, often unexpected, expenses as well.
The increased estate tax exemption, $5,490,000 per person or $10,980,000 per couple with portability in 2017, means thousands of policies that were bought to offset estate taxes are no longer needed. Only about 1/10 of 1 percent of Americans will be subject to federal estate taxes under the current law.
Additionally, even those liable for estate taxes will have reduced tax bills due to the lower maximum estate tax rate of 40 percent. And the likelihood of no federal estate tax looms large under the new administration.
While consumers have greater interest or need for life settlements, investors are showing an increasing appetite for life settlements too.
With the economy on the rebound, more capital is available for investment. Low interest rates, however, have investors searching for alternatives without additional exposure to the stock market, which is already at record highs. Life settlements are primarily a “mortality play” — an investment option that is not directly correlated to the stock market or interest rates.
With more historical experience available, investors are also gaining more confidence in life expectancy evaluations, the critical pricing tool for life settlement investors’ buying decisions.
This blog was originally published on LifeHealthPro.
To continue reading the blog please click here